CLINICAL_TRIALS
trial_result
· 2012-09-07
Clinical Trial Update: A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED) [Phase 1]
Summary
A completed Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of MK-1006 in individuals with type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2012-09-07